Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

387 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome.
Fisk DT, Meshnick S, Kazanjian PH. Fisk DT, et al. Among authors: meshnick s. Clin Infect Dis. 2003 Jan 1;36(1):70-8. doi: 10.1086/344951. Epub 2002 Dec 16. Clin Infect Dis. 2003. PMID: 12491205
Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia.
Zar HJ, Alvarez-Martinez MJ, Harrison A, Meshnick SR. Zar HJ, et al. Among authors: meshnick sr. Clin Infect Dis. 2004 Oct 1;39(7):1047-51. doi: 10.1086/424010. Epub 2004 Sep 7. Clin Infect Dis. 2004. PMID: 15472859
Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia.
Bartlett MS, Shaw MM, Smith JW, Meshnick SR. Bartlett MS, et al. Among authors: meshnick sr. Antimicrob Agents Chemother. 1998 Apr;42(4):934-5. doi: 10.1128/AAC.42.4.934. Antimicrob Agents Chemother. 1998. PMID: 9559812 Free PMC article.
Drug resistance in Pneumocystis carinii: an emerging problem.
Walker DJ, Meshnick SR. Walker DJ, et al. Among authors: meshnick sr. Drug Resist Updat. 1998;1(3):201-4. doi: 10.1016/s1368-7646(98)80040-x. Drug Resist Updat. 1998. PMID: 17092806
Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, Lee CH, Crane L, Katz J, Meshnick SR. Kazanjian P, et al. Among authors: meshnick sr. J Infect Dis. 2000 Aug;182(2):551-7. doi: 10.1086/315719. Epub 2000 Jul 28. J Infect Dis. 2000. PMID: 10915088 Clinical Trial.
Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
Kazanjian P, Locke AB, Hossler PA, Lane BR, Bartlett MS, Smith JW, Cannon M, Meshnick SR. Kazanjian P, et al. Among authors: meshnick sr. AIDS. 1998 May 28;12(8):873-8. doi: 10.1097/00002030-199808000-00009. AIDS. 1998. PMID: 9631140
Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
Armstrong W, Meshnick S, Kazanjian P. Armstrong W, et al. Among authors: meshnick s. Microbes Infect. 2000 Jan;2(1):61-7. doi: 10.1016/s1286-4579(00)00284-7. Microbes Infect. 2000. PMID: 10717542 Review.
Evaluation of sulfa drugs against recombinant Pneumocystis carinii dihydropteroate synthetase and in vivo.
Hong YL, Hossler P, Bartlett M, Queener S, Smith J, Meshnick S. Hong YL, et al. Among authors: meshnick s. J Eukaryot Microbiol. 1996 Sep-Oct;43(5):40S. doi: 10.1111/j.1550-7408.1996.tb04976.x. J Eukaryot Microbiol. 1996. PMID: 8822843 No abstract available.
Sulfa resistance in mouse-derived Pneumocystis carinii.
Lane B, Hossler P, Bartlett M, Queener S, O'Reilly T, Smith J, Meshnick S. Lane B, et al. Among authors: meshnick s. J Eukaryot Microbiol. 1996 Sep-Oct;43(5):39S. doi: 10.1111/j.1550-7408.1996.tb04975.x. J Eukaryot Microbiol. 1996. PMID: 8822842 No abstract available.
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
Kovacs JA, Gill VJ, Meshnick S, Masur H. Kovacs JA, et al. Among authors: meshnick s. JAMA. 2001 Nov 21;286(19):2450-60. doi: 10.1001/jama.286.19.2450. JAMA. 2001. PMID: 11712941
387 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback